<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-143520" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Renal Infarction</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mulayamkuzhiyil Saju</surname>
            <given-names>Jiya</given-names>
          </name>
          <aff>NYU Langone Health, Long Island Community Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leslie</surname>
            <given-names>Stephen W.</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jiya Mulayamkuzhiyil Saju declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephen Leslie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-143520.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Renal infarction is a rare ischemic event caused by the complete or partial occlusion of the main renal artery or its segmental branches, ultimately leading to ischemic renal necrosis. Renal infarction most commonly occurs due to an embolus originating from the heart or an in situ thrombosis. The diagnosis of renal infarction should be considered in patients who develop sudden abdominal or flank pain with reduced renal function, elevated LDH, hematuria, or proteinuria and who do not have urolithiasis or any other diagnosable explanation for their symptoms. Early diagnosis is essential for initiating revascularization therapy promptly, which optimizes renal function recovery. Treatment options include intravascular thrombolysis, systemic thrombolysis, surgery, anticoagulation, and medical management. Clinical presentation, underlying risk factors, length of time between symptom onset and treatment, and partial or total artery occlusion all impact the likelihood of renal recovery.&#x000a0;This course explores&#x000a0;evidence-based strategies for assessing risk factors, interpreting diagnostic imaging studies, and managing complications to enhance clinical decision-making in renal infarction management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate renal infarction from other causes of abdominal pain and renal dysfunction.</p></list-item><list-item><p>Screen patients efficiently for clinical indicators of renal infarction.</p></list-item><list-item><p>Implement timely revascularization therapy upon confirming renal infarction diagnosis.</p></list-item><list-item><p>Apply interprofessional team strategies to improve care coordination and patient outcomes in&#x000a0;renal infarction management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143520&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143520">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-143520.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Renal infarction is a rare ischemic event caused by the complete or partial occlusion of the main renal artery or its segmental branches, which may ultimately lead to renal ischemia. Renal infarction most commonly occurs due to an embolus originating from the heart or an in situ thrombosis.<xref ref-type="bibr" rid="article-143520.r1">[1]</xref>&#x000a0;Other etiological causes of renal infarction are aortic thromboembolism, trauma, renal artery dissection, coagulation disorders, or other atheroembolic disease.&#x000a0;</p>
        <p>The diagnosis of renal infarction should be considered in patients who develop sudden abdominal or flank pain with reduced renal function, elevated LDH, hematuria, or proteinuria and who do not have urolithiasis or any other diagnosable explanation for their symptoms. The chances increase if the patient has cardiac disease, especially atrial fibrillation, or is aged older than 60 years. Evaluation often starts with a noncontrast abdominal computed tomography (CT) scan, progressing to a contrast-enhanced study if the original CT scan is negative.<xref ref-type="bibr" rid="article-143520.r2">[2]</xref><xref ref-type="bibr" rid="article-143520.r3">[3]</xref>&#x000a0;Early diagnosis is essential for initiating revascularization therapy promptly, which optimizes renal function recovery. Treatment options include intravascular thrombolysis, systemic thrombolysis, anticoagulation, and antiplatelet therapy. Clinical presentation, underlying risk factors, length of time between symptom onset and treatment, and partial or total artery occlusion all impact the likelihood of renal recovery.</p>
        <p>Given the overlap of clinical symptoms with more common presentations (eg, renal calculi and pyelonephritis), the diagnosis may be missed entirely; this possibility is supported by a higher incidence of renal infarction in autopsy studies compared to retrospective case reviews.&#x000a0;An overlooked diagnosis can result in irreversible loss of renal function, as renal reperfusion therapy is ineffective in delayed presentation.<xref ref-type="bibr" rid="article-143520.r4">[4]</xref><xref ref-type="bibr" rid="article-143520.r5">[5]</xref></p>
      </sec>
      <sec id="article-143520.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The causes of renal infarction can be grouped into the following categories:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardioembolic sources</p>
          </list-item>
          <list-item>
            <p>Renal artery thrombosis</p>
          </list-item>
          <list-item>
            <p>Trauma or mechanical injury</p>
          </list-item>
          <list-item>
            <p>Aortic or renal artery dissection</p>
          </list-item>
          <list-item>
            <p>Hypercoagulability</p>
          </list-item>
          <list-item>
            <p>Atheroembolic disease&#x000a0;<xref ref-type="bibr" rid="article-143520.r6">[6]</xref><xref ref-type="bibr" rid="article-143520.r7">[7]</xref><xref ref-type="bibr" rid="article-143520.r8">[8]</xref><xref ref-type="bibr" rid="article-143520.r9">[9]</xref><xref ref-type="bibr" rid="article-143520.r10">[10]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Cardioembolic Disorders</bold>
</p>
        <p>Cardioembolic disorders are the most common etiology of renal infarction, accounting for up to 55% of cases. Within this group, between 64% to 75% are noted to have atrial fibrillation.<xref ref-type="bibr" rid="article-143520.r7">[7]</xref>&#x000a0;Renal infarction may be the first sign of atrial fibrillation. Also, many patients with atrial fibrillation who develop renal infarction are found to be subtherapeutic with anticoagulation.&#x000a0;Renal infarction due to cardiac emboli tends to occur in the older age group, often in the sixth to eighth decade of life. Other cardiac causes include cardiac emboli due to rheumatic mitral stenosis, myocardial infarction, and prosthetic or native valve endocarditis. Renal infarction can also occur from an embolus originating from an atrial myxoma or thrombus in the left ventricle apex.<xref ref-type="bibr" rid="article-143520.r11">[11]</xref>&#x000a0;</p>
        <p>
<bold>Renal Artery Thrombosis</bold>
</p>
        <p>Arterial causes of renal infarction include atherosclerotic thrombosis originating from the aorta or renal artery. Aneurysms of the thoracic or suprarenal abdominal aorta can also increase the risk of renal infarctions by favoring thrombi development. Treatment is aimed at treating risk factors such as hyperlipidemia and hypertension.<xref ref-type="bibr" rid="article-143520.r12">[12]</xref>&#x000a0;</p>
        <p>
<bold>Trauma or Mechanical Injury</bold>
</p>
        <p>Renal infarction can occur from a blunt abdominal injury leading to dissection or occlusion of the renal artery, which may result from direct trauma or retroperitoneal bleeding compressing renal vasculature. Surgery or endovascular repair may be indicated depending on the nature of the injury.&#x000a0;</p>
        <p>
<bold>Aortic or Renal Artery Dissection</bold>
</p>
        <p>Mechanical instrumentation is the most common cause of renal artery dissection, most often due to endovascular or surgical procedures involving the aorta or its branches. Aortic dissection can also involve 1 or both renal arteries, and endovascular stent placement during aortic repair can also affect the renal artery supply. Spontaneous renal artery dissection is very rare but can have significant sequelae in otherwise healthy patients. Clinicians should assess each patient for risk and individualize surgical or nonsurgical management determinations.<xref ref-type="bibr" rid="article-143520.r13">[13]</xref><xref ref-type="bibr" rid="article-143520.r14">[14]</xref></p>
        <p>Fibromuscular dysplasia occurs primarily in women younger than 50 and usually involves the renal arteries, about half the time, bilaterally.<xref ref-type="bibr" rid="article-143520.r15">[15]</xref> Fibromuscular dysplasia affects small and medium-sized arteries, causing stenosis, aneurysm, or dissection. Renal infarctions can occur due to thrombus formation in the poststenotic, dilated portion of the artery, which usually manifests initially as hypertension.<xref ref-type="bibr" rid="article-143520.r16">[16]</xref><xref ref-type="bibr" rid="article-143520.r17">[17]</xref>&#x000a0;See StatPearls' companion reference,&#x000a0;"<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/21736">Fibromuscular Dysplasia</ext-link>," for further information.<xref ref-type="bibr" rid="article-143520.r18">[18]</xref> Renal artery dissection can occur spontaneously in fibromuscular dysplasia, Marfan syndrome, and Ehler-Danlos syndrome.<xref ref-type="bibr" rid="article-143520.r19">[19]</xref><xref ref-type="bibr" rid="article-143520.r20">[20]</xref></p>
        <p>
<bold>Hypercoagulable State</bold>
</p>
        <p>Heritable coagulation disorders like protein C and protein S deficiency, hyperhomocysteinemia, systemic lupus erythematous, polycythemia vera, Factor V Leiden mutation, prothrombin gene mutation, and antithrombin III deficiency can also lead to renal artery blockage.&#x000a0;Renal infarction may also be seen with oral contraceptive use, COVID-19 infection, malignancy, sickle cell disease, anabolic steroid abuse, and cocaine use.<xref ref-type="bibr" rid="article-143520.r21">[21]</xref><xref ref-type="bibr" rid="article-143520.r22">[22]</xref></p>
        <p>
<bold>Atheroembolic Disease</bold>
</p>
        <p>The majority of patients who receive angiography have significant atherosclerotic disease, which puts them at higher risk for atherosclerotic plaque emboli, resulting in renal artery occlusion and infarction. The incidence of acute kidney injury (AKI) in patients older than 60 years due to biopsy-confirmed renal atheroemboli has been reported at 7%, which can be reduced using a brachial rather than an iliofemoral approach for arterial access.<xref ref-type="bibr" rid="article-143520.r23">[23]</xref><xref ref-type="bibr" rid="article-143520.r24">[24]</xref>&#x000a0;</p>
        <p>In contrast to other causes of AKI, atheroembolic disease can present with renal injury gradually and weeks after the initial insult.<xref ref-type="bibr" rid="article-143520.r25">[25]</xref>&#x000a0;Symptoms are generally less severe because atheroemboli often have irregular shapes and do not typically cause complete occlusion, as do thromboemboli.<xref ref-type="bibr" rid="article-143520.r26">[26]</xref>&#x000a0;Over time, this results in a narrowed arterial lumen and some degree of renal injury over several weeks.<xref ref-type="bibr" rid="article-143520.r27">[27]</xref><xref ref-type="bibr" rid="article-143520.r28">[28]</xref>&#x000a0;</p>
        <p>
<bold>Idiopathic</bold>
</p>
        <p>Despite extensive evaluation, many patients do not have an identifiable cause of renal infarction. About 20% to 30% of cases remain idiopathic, with a median age of approximately 50 years in these patients.<xref ref-type="bibr" rid="article-143520.r6">[6]</xref><xref ref-type="bibr" rid="article-143520.r7">[7]</xref><xref ref-type="bibr" rid="article-143520.r10">[10]</xref>&#x000a0;The infarction may represent poor vascular health in general, and all secondary risk factors, including hypertension, hyperlipidemia, and diabetic control, should be aggressively treated.<xref ref-type="bibr" rid="article-143520.r29">[29]</xref>&#x000a0;A study found that patients with idiopathic causes were more likely to be younger and smokers, suggesting targets for secondary prevention.<xref ref-type="bibr" rid="article-143520.r30">[30]</xref></p>
      </sec>
      <sec id="article-143520.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Autopsy studies suggest the incidence of renal infarction is 14 per 1000, or 1.4%.<xref ref-type="bibr" rid="article-143520.r6">[6]</xref>&#x000a0;Other retrospective studies of ER admissions found an incidence of 0.004% to 0.007%.<xref ref-type="bibr" rid="article-143520.r30">[30]</xref><xref ref-type="bibr" rid="article-143520.r31">[31]</xref>&#x000a0;Many renal infarctions are diagnosed late or misdiagnosed; therefore, autopsy studies may be more accurate.<xref ref-type="bibr" rid="article-143520.r30">[30]</xref><xref ref-type="bibr" rid="article-143520.r32">[32]</xref>&#x000a0;A study found unilateral renal involvement in 81% of cases and bilateral involvement in 19%.<xref ref-type="bibr" rid="article-143520.r9">[9]</xref>&#x000a0;Patients with hypercoagulability may be more likely to have multiple and bilateral infarcts.<xref ref-type="bibr" rid="article-143520.r6">[6]</xref>&#x000a0;The mean age of patients who present with renal infarction is thought to be approximately 63 years, with&#x000a0;no&#x000a0;significant difference in sex distribution.<xref ref-type="bibr" rid="article-143520.r9">[9]</xref><xref ref-type="bibr" rid="article-143520.r19">[19]</xref>&#x000a0;Risk factors for renal infarction include atrial fibrillation, hypertension, diabetes, and prior embolic infarction.<xref ref-type="bibr" rid="article-143520.r9">[9]</xref><xref ref-type="bibr" rid="article-143520.r30">[30]</xref></p>
      </sec>
      <sec id="article-143520.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Thrombotic mechanisms involve endothelial injury, which activates in-situ thrombus formation. Another ischemic mechanism occurs when emboli from the heart in atrial fibrillation become dislodged and eventually occlude the renal artery.&#x000a0;All renal segmental arteries are end-arteries, so a&#x000a0;complete or partial reduction in vascular flow due to embolic or thrombotic occlusion leads to renal ischemia and infarction with focal tissue necrosis of the kidney (see <bold>Image.</bold> Renal Tissue Necrosis).&#x000a0;The consequent impairment in renal function can manifest as elevated creatinine levels and decreased glomerular filtration rates (GFR), leading to AKI, chronic kidney disease (CKD), and sometimes end-stage renal failure.&#x000a0;</p>
        <p>Atheroemboli is more irregular than thrombus-based emboli, but the crystals are smaller. They are, therefore, more likely to produce an incomplete renal arterial blockage than thromboemboli and tend to affect smaller branches.<xref ref-type="bibr" rid="article-143520.r26">[26]</xref>&#x000a0;The atheroemboli&#x000a0;eventually cause a foreign body reaction with giant cell formation, narrowing the arterial lumen and reducing renal blood flow, resulting in renovascular hypertension and reduced GFR.<xref ref-type="bibr" rid="article-143520.r27">[27]</xref><xref ref-type="bibr" rid="article-143520.r28">[28]</xref></p>
        <p>An infarction of the main renal artery jeopardizes the function of the entire organ. Segmental arterial occlusion can lead to reduced function of a large portion of the kidney, which is especially significant when associated with preexisting renal failure or solitary kidneys. Blockage of a subsegmental artery leads to the classic "wedge-shaped" diffusion defect of the renal parenchyma seen on contrast-enhanced CT scans of the abdomen.</p>
      </sec>
      <sec id="article-143520.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical Features</bold>
</p>
        <p>Patients with acute renal infarctions typically present with a sudden onset of abdominal or flank pain along with associated symptoms, including nausea, vomiting, hematuria, and occasionally fever.&#x000a0;On physical examination, abdominal or loin tenderness findings may be present.<xref ref-type="bibr" rid="article-143520.r5">[5]</xref><xref ref-type="bibr" rid="article-143520.r6">[6]</xref>&#x000a0;Skin color changes are noted in approximately one-third of cases (eg, "blue toe" syndrome or livedo reticularis).<xref ref-type="bibr" rid="article-143520.r33">[33]</xref><xref ref-type="bibr" rid="article-143520.r34">[34]</xref>&#x000a0;</p>
        <p>Unfortunately, the clinical presentation is often nonspecific or suggestive of alternative, more common disorders, including ureteral colic, a "passed" kidney stone, pyelonephritis, or gastroenteritis. This confusion often leads to a delay, with fewer than 50% of patients receiving the correct diagnosis within 2 days of their initial presentation.<xref ref-type="bibr" rid="article-143520.r35">[35]</xref>&#x000a0;Signs of acute kidney injury may only appear several weeks after the actual injurious event. The triad of&#x000a0;sudden abdominal or flank pain, elevated lactate dehydrogenase (LDH), and hematuria and proteinuria suggest renal infarction.<xref ref-type="bibr" rid="article-143520.r31">[31]</xref></p>
        <p>Since these cases often present with vague symptoms, a high index of suspicion is necessary for accurate diagnosis. Risk factors for general atherosclerotic disease include male gender, significant smoking history, hypertension, hypercholesterolemia, diabetes, and older age. Atrial fibrillation is a pervasive source of emboli causing renal infarction.<xref ref-type="bibr" rid="article-143520.r36">[36]</xref><xref ref-type="bibr" rid="article-143520.r37">[37]</xref>&#x000a0;Fundoscopic examination is suggested in suspected cases of atherosclerotic emboli to identify retinal abnormalities.<xref ref-type="bibr" rid="article-143520.r38">[38]</xref></p>
        <p>Acute loss of renal arterial supply can lead to new-onset, renin-mediated hypertension noted at the time of initial presentation, which usually improves with treatment.<xref ref-type="bibr" rid="article-143520.r4">[4]</xref>&#x000a0;Unfortunately, this hypertension is often attributed to a pain response and frequently goes unrecognized.<xref ref-type="bibr" rid="article-143520.r8">[8]</xref>&#x000a0;Some patients may be asymptomatic, further contributing to the underdiagnosis of renal infarction.&#x000a0;Asymptomatic renal infarction can also be detected incidentally in patients undergoing imaging for unrelated reasons.<xref ref-type="bibr" rid="article-143520.r39">[39]</xref>&#x000a0;Atherosclerotic renal emboli as a cause of renal infarction is suggested by the following clinical features:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>History of a precipitating event in the past 6 months (eg, angiography); the most significant risk factor for cholesterol emboli</p>
          </list-item>
          <list-item>
            <p>Acute or subacute kidney injury</p>
          </list-item>
          <list-item>
            <p>Skin color changes <xref ref-type="bibr" rid="article-143520.r33">[33]</xref><xref ref-type="bibr" rid="article-143520.r34">[34]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Cholesterol crystals found in the retina (ie, Hollenhorst plaques) on fundoscopic examination&#x000a0;<xref ref-type="bibr" rid="article-143520.r38">[38]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-143520.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Laboratory Studies</bold>
</p>
        <p>Laboratory findings&#x000a0;in renal infarction&#x000a0;include leukocytosis, elevated C-reactive protein (CRP), very high LDH, macroscopic or microscopic hematuria, and proteinuria.<xref ref-type="bibr" rid="article-143520.r35">[35]</xref><xref ref-type="bibr" rid="article-143520.r40">[40]</xref>&#x000a0;Other possible lab findings are elevated creatinine and creatine kinase values. The rise in creatinine is more evident in patients with a particularly large renal infarct or bilateral involvement of both kidneys.<xref ref-type="bibr" rid="article-143520.r6">[6]</xref>&#x000a0;A careful assessment of coagulation disorders should also be performed if cardiac and renal arterial pathology have been eliminated as causative factors of renal infarction or if surgical revascularization is being considered.&#x000a0;LDH is a marker of cell necrosis and can rise to 4 or 5 times the normal value with no similar rise in serum aspartate aminotransferase (AST) and alanine transaminase (ALT) in renal infarction; this does not occur with other etiologies (eg, urolithiasis, renal colic, or pyelonephritis).<xref ref-type="bibr" rid="article-143520.r4">[4]</xref><xref ref-type="bibr" rid="article-143520.r41">[41]</xref><xref ref-type="bibr" rid="article-143520.r42">[42]</xref> Elevated LDH also occurs with&#x000a0;myocardial infarction, hemolysis, and renal transplant rejection, which are usually clinically distinguishable from renal infarctions.<xref ref-type="bibr" rid="article-143520.r42">[42]</xref>&#x000a0;LDH can remain elevated up to 15 days after the first clinical symptoms.<xref ref-type="bibr" rid="article-143520.r6">[6]</xref>&#x000a0;</p>
        <p>Cholesterol emboli&#x000a0;causing renal infarction are often associated with eosinophilia, eosinophiluria, and low serum complement in the acute phase. However, these findings dissipate after about 1 week from the time of the injury.<xref ref-type="bibr" rid="article-143520.r43">[43]</xref><xref ref-type="bibr" rid="article-143520.r44">[44]</xref><xref ref-type="bibr" rid="article-143520.r45">[45]</xref>&#x000a0;Focal neurological defects, mental confusion, localized cyanosis, and retinal Hollenhorst plaques suggest atherosclerotic emboli.<xref ref-type="bibr" rid="article-143520.r1">[1]</xref>&#x000a0;Atheroemboli also tend to produce a slow and often subacute decrease in renal function, which typically plateaus at 3 to 8 weeks.<xref ref-type="bibr" rid="article-143520.r27">[27]</xref>&#x000a0;Clinical diagnosis of atheroembolic disease is often missed; renal biopsy can be necessary for a definitive diagnosis. Atheroemboli is detected in over 75% of cases. Intraluminal cholesterol crystals appear as biconvex, needle-shaped defects, or "ghosts" as the cholesterol dissolves during the fixation process.<xref ref-type="bibr" rid="article-143520.r46">[46]</xref><xref ref-type="bibr" rid="article-143520.r47">[47]</xref>&#x000a0;Significant vascular intimal inflammation and possibly eosinophilic infiltration.<xref ref-type="bibr" rid="article-143520.r44">[44]</xref>&#x000a0;Focal glomerulosclerosis may also be seen.<xref ref-type="bibr" rid="article-143520.r47">[47]</xref><xref ref-type="bibr" rid="article-143520.r48">[48]</xref></p>
        <p>
<bold>Imaging Studies</bold>
</p>
        <p>Noninvasive imaging studies&#x000a0;in patients presenting with acute flank pain, vomiting, and hematuria usually start with a noncontrast CT scan of the abdomen and pelvis to rule out urolithiasis and pyelonephritis, which are the most common reasons for such a clinical presentation.<xref ref-type="bibr" rid="article-143520.r49">[49]</xref>&#x000a0;However, with renal infarction, noncontrast CT may show only perinephric stranding, mild renal swelling, or no significant abnormality (see <bold>Image</bold>. Renal Infarction). If a noncontrast CT is not diagnostic, a contrast-enhanced abdominal CT should be performed to look for renal infarction.<xref ref-type="bibr" rid="article-143520.r19">[19]</xref><xref ref-type="bibr" rid="article-143520.r20">[20]</xref>&#x000a0;Clinicians should consider renal infarction in patients with a high risk of thromboembolic events, high LDH levels, or hematuria.<xref ref-type="bibr" rid="article-143520.r30">[30]</xref>&#x000a0;</p>
        <p>CT with contrast often shows a clear hypodensity or wedge-shaped perfusion defect in the kidney, best appreciated in the arterial phase. With a segmental infarct, there may be a thin rim of the renal cortex paralleling the wedge-shaped area of the infarct, presenting with normal enhancement. This finding is called the cortical rim sign, which is seen in about half of the cases of renal infarction.<xref ref-type="bibr" rid="article-143520.r50">[50]</xref><xref ref-type="bibr" rid="article-143520.r51">[51]</xref>&#x000a0;The cortical rim sign may become evident several days after a renal infarction due to preserved perfusion of the capsule by perforating branches of the renal capsular artery, receiving collateral circulation from branches of the suprarenal, ureteral, and lumbar vessels.<xref ref-type="bibr" rid="article-143520.r52">[52]</xref>&#x000a0;If there is total occlusion of the main renal artery, there can be nonenhancement of the entire kidney. In a traumatic transection of the renal artery, CT of the abdomen may reveal a hematoma starting at the hilum of the renal artery. Intervention is likely ineffective if the kidney is atrophic or scarred.&#x000a0;Renal CT arteriography is the gold standard investigation for renal infarction and&#x000a0;makes the definitive diagnosis, allowing for proper treatment decision-making.<xref ref-type="bibr" rid="article-143520.r19">[19]</xref>&#x000a0;Renal magnetic resonance imaging (MRI) arteriography is equally helpful, but the examination takes much longer, so CT imaging is usually preferred. Other investigations used to confirm the diagnosis of renal infarction are&#x000a0;dimercaptosuccinic acid (DMSA) radioisotope scans.</p>
        <p>Renal artery dopplers are often used to evaluate for renal artery stenosis but cannot assess nonstenotic lesions and determine etiology.<xref ref-type="bibr" rid="article-143520.r29">[29]</xref>&#x000a0;Image quality can also be significantly affected by body habitus.&#x000a0;A color Doppler scan may also be beneficial in demonstrating decreased or absent blood flow to the infarcted area. An intravenous pyelogram (IVP) in a renal infarction demonstrates nonvisualization of the infarcted renal parenchyma. A DMSA radioisotope scan will reveal decreased or no tracer uptake in the affected area.<xref ref-type="bibr" rid="article-143520.r4">[4]</xref>&#x000a0;</p>
        <p>Invasive vascular ultrasound (IVUS) is a newer modality to add diagnostic accuracy for renal infarctions. This method adds information regarding the arterial walls that are not always visualized by arteriography, which primarily images the arterial lumens.&#x000a0;IVUS can also help differentiate thrombosis, dissection, and fibromuscular dysplasia. This modality has been used primarily in cardiovascular evaluations, and further study is needed for renal artery imaging.<xref ref-type="bibr" rid="article-143520.r29">[29]</xref><xref ref-type="bibr" rid="article-143520.r53">[53]</xref></p>
        <p>
<bold>Additional Cardiac Studies</bold>
</p>
        <p>Cardiac studies, including an ECG or Holter monitoring, should evaluate for atrial fibrillation in all patients diagnosed with renal infarction without an apparent cause. A transthoracic or transesophageal echocardiogram can determine the possibility of cardiac thromboembolic disease and thrombi.<xref ref-type="bibr" rid="article-143520.r52">[52]</xref></p>
      </sec>
      <sec id="article-143520.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>CT renal angiography is performed to better evaluate the vasculature, identify the specific vessels involved, and determine the degree of occlusion. Revascularization is not useful if imaging demonstrates a shrunken, atrophic kidney or a clearly demarcated, dense wedge-shaped scar suggesting an old infarction.&#x000a0;Treating renal infarction can be broadly categorized into catheter-directed thrombolysis, systemic thrombolysis, anticoagulation, surgery, and experimental treatment.</p>
        <p>The factors used to determine if a patient would benefit from revascularization procedures include the time since ischemia onset, current kidney function, renal infarct size and extent, the presence of arterial dissection, contralateral kidney function, the precise vessels involved, and whether renal artery occlusion is partial or complete.&#x000a0;Determining the time of the infarction onset may not always be straightforward. Acute symptoms (eg, flank pain, nausea, vomiting, and hypertension) suggest a more recent onset of 1 week or less.&#x000a0;Typically, even complete occlusions of &#x02264;6 hours are considered potentially reversible.&#x000a0;Patients with normal kidney function may not initially show an elevated BUN and creatinine even with complete, acute, unilateral renal arterial occlusion. The degree of renal arterial blockage can be determined by CT renal angiography. Partial occlusion with some degree of visualized parenchymal perfusion suggests potential recovery.</p>
        <p><bold>Catheter-Directed Thrombolysis</bold>&#x000a0;</p>
        <p>Catheter-directed thrombolysis, or percutaneous endovascular therapy, is used to revascularize proximal or bilateral renal artery occlusions and restore perfusion in a solitary kidney. Catheter-directed thrombolysis may also be considered for selected patients with significant segmental artery occlusions. Modalities, including local intraarterial thrombolysis, thrombectomy, angioplasty, or stenting, are more effective when performed as close to the onset of clinical symptoms.<xref ref-type="bibr" rid="article-143520.r54">[54]</xref>&#x000a0;Most patients show complete or at least partial vascular reperfusion if diagnosed and treated promptly, and case reports have shown successful revascularization for up to 96 hours after presentation.<xref ref-type="bibr" rid="article-143520.r55">[55]</xref><xref ref-type="bibr" rid="article-143520.r56">[56]</xref><xref ref-type="bibr" rid="article-143520.r57">[57]</xref><xref ref-type="bibr" rid="article-143520.r58">[58]</xref>&#x000a0;Following catheter-directed thrombolysis, laboratory markers of renal recovery may lag behind functional kidney improvement. One study demonstrated long-term recovery of renal function despite no significant improvement in the BUN and creatinine at the time of hospital discharge. Likely, some renal tissue was reperfused and recovered over time, similar to "myocardial stunning."<xref ref-type="bibr" rid="article-143520.r37">[37]</xref></p>
        <p>One published protocol attempts thrombectomy first; if unsuccessful, a bolus injection of 250,000 IU of urokinase is given directly into the affected artery. If results are not deemed adequate, the catheter is left in place, and a continuous infusion of urokinase at a rate of 50,000 IU per hour is utilized for up to 72 hours. Daily renal angiograms are done while the urokinase infusion is administered, and the patients are carefully monitored for possible complications. If the infarction remains unchanged after 72 hours, the treatment is ineffective and discontinued.<xref ref-type="bibr" rid="article-143520.r37">[37]</xref>&#x000a0;Other thrombolytic agents like urokinase, streptokinase, or tissue plasminogen activator have also been used.&#x000a0;If thrombolysis is ineffective, angioplasty with or without stenting can be considered, but no definitive guidelines exist. The complications of catheter-directed thrombolysis include bleeding, pseudoaneurysm formation, and acute mesenteric embolism with ischemia.<xref ref-type="bibr" rid="article-143520.r59">[59]</xref>&#x000a0;Typically, patients who undergo angioplasty or stenting receive 3 to 6 months of aspirin and clopidogrel.&#x000a0;Ultrasound-enhanced catheter-directed thrombolysis&#x000a0;is a novel treatment option for renal artery thrombosis, wherein the ultrasound waves allow better penetration of thrombolytic agents by acoustic streaming.<xref ref-type="bibr" rid="article-143520.r60">[60]</xref>&#x000a0;Following endovascular therapy, patients are maintained on aspirin and clopidogrel; the clopidogrel can be discontinued after 3 months.<xref ref-type="bibr" rid="article-143520.r60">[60]</xref></p>
        <p><bold>Systemic Thrombolysis</bold>&#x000a0;</p>
        <p>Systemic thrombolysis can be attempted if catheter-directed thrombolysis is not available.<xref ref-type="bibr" rid="article-143520.r61">[61]</xref><xref ref-type="bibr" rid="article-143520.r62">[62]</xref> However, the risk of systemic bleeding is higher in systemic fibrinolytic therapy than in catheter-directed thrombolysis.<xref ref-type="bibr" rid="article-143520.r4">[4]</xref>&#x000a0;Compared to systemic fibrinolysis, catheter-directed thrombolysis has the advantage of a lower dosage of thrombolytic agents and easier deliverability to the target blood vessels.<xref ref-type="bibr" rid="article-143520.r60">[60]</xref>&#x000a0;Reperfusion injury is a potential complication of thrombolysis.&#x000a0;</p>
        <p>Anticoagulation or antiplatelet agents&#x000a0;are considered the treatment of choice for patients who present several days or longer after a renal infarction, as revascularization therapy is not likely to be beneficial. Long-term anticoagulation is initiated for those with underlying hypercoagulation disorders or cardioembolic disease. The duration of anticoagulation is typically at least 6 months if the patient does not have risk factors for repeat embolization. Intravenous heparin, followed by warfarin, with a target INR of 2 to 3, is commonly used. In patients already on warfarin with a therapeutic INR before their renal infarct, an increased INR target of 2.5 to 3.5 is suggested.&#x000a0;Direct oral anticoagulants (eg, Factor Xa inhibitors) are frequently used for anticoagulation indications and do not require the frequent monitoring associated with long-term warfarin therapy. If anticoagulants are stopped after 6 months, life-long aspirin has been recommended for patients with renal infarction, even if no specific hypercoagulable state has been identified. Aspirin may also benefit those with asymptomatic remote renal infarctions who present with an atrophic kidney.</p>
        <p>
<bold>Surgical Therapy</bold>
</p>
        <p>Open surgery is mostly attempted in the event of trauma-related renal artery injury and aortic dissection extending into the renal artery.&#x000a0;Various surgical options include arteriotomy with embolectomy, aorto-renal, ileo-renal, or splenorenal bypass procedures.<xref ref-type="bibr" rid="article-143520.r40">[40]</xref>&#x000a0;Clinicians should refer patients with underlying fibromuscular dysplasia to specialists for possible percutaneous transluminal angioplasty or vascular reconstructive surgery. Surgical intervention has not proven effective in thrombotic and embolic etiologies and is associated with significant risks.<xref ref-type="bibr" rid="article-143520.r37">[37]</xref></p>
        <p>
<bold>Antihypertensive Medications&#x000a0;</bold>
</p>
        <p>Antihypertensive medications inhibiting the renin-angiotensin axis are preferred for renovascular hypertension, which often develops in the first week after a renal infarction due to increased renin levels. The associated hypertension frequently subsides in the following weeks unless underlying essential hypertension exists.<xref ref-type="bibr" rid="article-143520.r37">[37]</xref><xref ref-type="bibr" rid="article-143520.r39">[39]</xref>&#x000a0;Long-term management of high blood pressure should be the same as for any hypertensive patient.<xref ref-type="bibr" rid="article-143520.r37">[37]</xref></p>
        <p>
<bold>Atherosclerotic Emboli Therapy</bold>
</p>
        <p>Atherosclerotic emboli treatment in the renal arteries is primarily supportive.<xref ref-type="bibr" rid="article-143520.r63">[63]</xref><xref ref-type="bibr" rid="article-143520.r64">[64]</xref>&#x000a0;Scheduled angiographic and vascular procedures should be canceled, postponed, or delayed. Patients with renal infarcts due to atheroemboli have a relatively poor overall prognosis due to the severity of their underlying atherosclerotic disease.&#x000a0;However, patients without significant comorbidities or complications can see their renal function improve over time, as shown in a study where 24% fully recovered.<xref ref-type="bibr" rid="article-143520.r27">[27]</xref>&#x000a0;Patients should follow general measures, including aspirin use, smoking cessation, hypertension control, weight management, and glycemic control.<xref ref-type="bibr" rid="article-143520.r1">[1]</xref><xref ref-type="bibr" rid="article-143520.r65">[65]</xref>&#x000a0;</p>
        <p>
<bold>Surveillance Recommendations</bold>
</p>
        <p>Long-term follow-up for patients with thromboembolic renal infarctions has not been standardized. Monitoring patients for complications related to ongoing therapy (eg, bleeding episodes) and regularly checking renal function is reasonable. Lifelong aspirin therapy is typically recommended as well.<xref ref-type="bibr" rid="article-143520.r10">[10]</xref><xref ref-type="bibr" rid="article-143520.r66">[66]</xref>&#x000a0;</p>
        <p>Follow-up imaging is recommended, and some experts have suggested serial abdominal imaging, preferably with MRI, at 6 and 12 months. If no new lesions or concerns are found, further surveillance imaging may not be necessary. Patients with underlying renal or cardiac issues will require closer and longer-term monitoring.&#x000a0;</p>
      </sec>
      <sec id="article-143520.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Diagnoses in the differential for renal infarction include the following: aortic aneurysm, aortic dissection, appendicitis, diverticulitis, gastroenteritis, mesenteric ischemia, nephrolithiasis, pyelonephritis, renal cell carcinoma, and gynecologic disorders.&#x000a0;Nephrolithiasis&#x000a0;and pyelonephritis are commonly confused for renal infarction. Failure to consider renal infarction as a differential in a case of flank pain initially suspected as renal colic could delay diagnosis and make renal function unsalvageable with reperfusion therapy.&#x000a0;Significant LDH elevation is not seen in pyelonephritis or nephrolithiasis and can be used to help distinguish these disorders from renal infarction, especially if serum transaminases are low.&#x000a0;A contrast-enhanced CT scan of the abdomen is crucial to help differentiate renal infarction from extrarenal causes of abdominal pain. Clinicians should exclude mesenteric ischemia because systemic embolization in a patient with atrial fibrillation or hypercoagulable disorder could potentially occlude the blood vessels supplying the intestine, leading to acute bowel infarction; angiography may be required for evaluation.</p>
      </sec>
      <sec id="article-143520.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>One large retrospective review found approximately 20% of patients diagnosed with renal infarction had died at 40 months; however, only 2% of these patients progressed to ESRD. The poor prognosis suggests that renal infarction is indicative of cardiac and other mortality.&#x000a0;<xref ref-type="bibr" rid="article-143520.r29">[29]</xref>&#x000a0;Prognosis is improved&#x000a0;with early diagnosis. Warm ischemia time, collateral flow, and preexisting kidney disease tend to influence prognosis following treatment with catheter-directed thrombolysis.<xref ref-type="bibr" rid="article-143520.r55">[55]</xref>&#x000a0;Prognosis can also be influenced by embolic infarction in other organs like the spleen, intestine, liver, and lungs.<xref ref-type="bibr" rid="article-143520.r19">[19]</xref>&#x000a0;The presence of extrarenal embolisms increases the duration of hospital stay as well as the overall morbidity and mortality.<xref ref-type="bibr" rid="article-143520.r11">[11]</xref></p>
      </sec>
      <sec id="article-143520.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Common complications include acute kidney injury, chronic kidney disease, and hypertension. The progression to CKD from AKI correlates with the magnitude of the infarction.<xref ref-type="bibr" rid="article-143520.r67">[67]</xref>&#x000a0;The main risk factors for CKD are advanced age and a higher degree of AKI.&#x000a0;Up to 58%&#x000a0;of renal infarction patients developed CKD, as detected in follow-up renal scintigraphy.<xref ref-type="bibr" rid="article-143520.r67">[67]</xref><xref ref-type="bibr" rid="article-143520.r68">[68]</xref><xref ref-type="bibr" rid="article-143520.r69">[69]</xref></p>
      </sec>
      <sec id="article-143520.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Nephrologists, hematologists, and cardiologists may require consultation.<xref ref-type="bibr" rid="article-143520.r5">[5]</xref>&#x000a0;Patients also need follow-up with vascular surgery or interventional radiology if recurrent vascular lesions like fibromuscular dysplasia are discovered. Follow-up is necessary because inflammation may prevent the accurate detection of fibromuscular dysplasia in the acute phase of renal infarction. Clinicians must also assess the carotid and other extra-renal arteries if suspected of fibromuscular dysplasia or other vasculopathies like Ehler-Danlos syndrome.<xref ref-type="bibr" rid="article-143520.r52">[52]</xref></p>
      </sec>
      <sec id="article-143520.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be educated regarding anticoagulation and INR range if warfarin is used. Those developing repeated infarcts, even&#x000a0;with anticoagulant&#x000a0;therapy, must be educated regarding medication compliance and reactivity with certain food items. Clinicians should also counsel patients to address other risk factors (eg, smoking cessation) with lifestyle modifications.</p>
      </sec>
      <sec id="article-143520.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Key factors to bear in mind when managing renal infarction include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Given the rarity of this condition, clinicians must have a high suspicion for clinical diagnosis, especially in patients with significant risk factors.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Patients with a history of atrial fibrillation, older age, and recent vascular instrumentation are at exceptionally high risk for renal infarction.</p>
          </list-item>
          <list-item>
            <p>A renal infarction should be suspected whenever a patient presents with acute flank pain and hematuria without evidence of a UTI, hydronephrosis, or urinary calculi.</p>
          </list-item>
          <list-item>
            <p>If the initial noncontrast CT is negative, immediate contrast-enhanced CT of the abdomen should be&#x000a0;performed to allow&#x000a0;the opportunity for effective revascularization.</p>
          </list-item>
          <list-item>
            <p>Elevated LDH with a normal AST/ALT is suggestive of renal infarction.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>A CT angiogram is the definitive test to confirm the diagnosis.</p>
          </list-item>
          <list-item>
            <p>Laboratory work for patients diagnosed with a renal infarction should include a urinalysis, serum aminotransferases, creatinine, LDH levels, and an EKG and coagulation studies.</p>
          </list-item>
          <list-item>
            <p>Rapid diagnosis allows for possible immediate catheter-directed thrombolysis therapy, the optimal recommended treatment, ideally administered within 6 hours of the infarction.</p>
          </list-item>
          <list-item>
            <p>There is controversy regarding when catheter-directed thrombolysis can be administered, but there are anecdotal reports of a benefit even after the usually recommended time limits.</p>
          </list-item>
          <list-item>
            <p>If catheter-directed thrombolysis therapy is unavailable, systemic thrombolytic therapy should be considered.</p>
          </list-item>
          <list-item>
            <p>Patients may also require secondary prevention in the form of antiplatelet therapy, and most, if not all, should be on some permanent anticoagulation or antiplatelet therapy.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-143520.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The involvement of an interprofessional team composed of primary clinicians (eg, physicians, nurse practitioners, and physician assistants), interventional radiologists, nephrologists, cardiologists, hematologists, and vascular surgeons are required to manage renal infarction. Nursing staff and pharmacists round out the interprofessional team.&#x000a0;While a clinician diagnoses the case of renal infarction, endovascular procedures are referred to an interventional radiologist or vascular surgeon. Complications such as acute kidney injury may need evaluation from a nephrologist. The etiology of renal infarction may require consultation with a cardiologist and hematologist. A combined approach by all these clinicians helps identify and tackle the rare and challenging diagnosis of renal infarction.</p>
        <p>Nursing supports patient examination and counseling, surgical preparation and assistance during surgery, and postoperative care. Pharmacists will be critical in all these cases, particularly with anticoagulation regimens, medication reconciliation, and patient counseling.&#x000a0;Any interprofessional healthcare team member who notes a change in patient status, performs an intervention, or notes an adverse event should immediately record their findings in the patient's chart and notify other team members to implement corrective action. This interprofessional information sharing and collaborative action will optimize patient outcomes in renal infarction cases and help prevent adverse results.</p>
      </sec>
      <sec id="article-143520.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143520&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143520">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/kidney-health/renal-infarction/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=143520">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/143520/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=143520">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-143520.s17">
        <fig id="article-143520.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Renal Infarction. CT imaging&#x000a0;of a patient with renal infarction. Contributed by S Lange, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Renal__infarct" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-143520.s18">
        <fig id="article-143520.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Renal Tissue Necrosis. The histologic image shows the edge of a renal infarct of an otherwise normal kidney (upper left) with necrotic tubules and glomeruli in the infarct area having preserved cellular outlines with loss of nuclei. Interstitial hemorrhage and mild inflammatory infiltrates can be seen at the border of the infarct. (H&#x00026;E stain 4X) Department of Pathology, Calicut Medical College, (CC By-SA 4.0 https://creativecommons.org/licenses/by-sa/4.0)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Renal_Infarct2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-143520.s19">
        <title>References</title>
        <ref id="article-143520.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scolari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ravani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gaggi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Santostefano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rollino</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stabellini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Colla</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Viola</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Maiorca</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Venturelli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bonardelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Faggiano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors.</article-title>
            <source>Circulation</source>
            <year>2007</year>
            <month>Jul</month>
            <day>17</day>
            <volume>116</volume>
            <issue>3</issue>
            <fpage>298</fpage>
            <page-range>298-304</page-range>
            <pub-id pub-id-type="pmid">17606842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markabawi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Singh-Gambhir</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Acute renal infarction: A diagnostic challenge.</article-title>
            <source>Am J Emerg Med</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>1325.e1</fpage>
            <page-range>1325.e1-1325.e2</page-range>
            <pub-id pub-id-type="pmid">29699899</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khokhar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thirumaran</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A rare case of renal infarction due to heroin and amphetamine abuse: case report.</article-title>
            <source>BMC Nephrol</source>
            <year>2022</year>
            <month>Jan</month>
            <day>12</day>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <pub-id pub-id-type="pmid">35021999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saeed</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Renal infarction.</article-title>
            <source>Int J Nephrol Renovasc Dis</source>
            <year>2012</year>
            <volume>5</volume>
            <fpage>119</fpage>
            <page-range>119-23</page-range>
            <pub-id pub-id-type="pmid">22969301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seetho</surname>
                <given-names>IW</given-names>
              </name>
              <name>
                <surname>Bungay</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Taal</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Fluck</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Renal infarction in patients presenting with suspected renal colic.</article-title>
            <source>NDT Plus</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>362</fpage>
            <page-range>362-4</page-range>
            <pub-id pub-id-type="pmid">25949343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourgault</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grimbert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Verret</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pourrat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Herody</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Halimi</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Karras</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amoura</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Jourde-Chiche</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Izzedine</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fran&#x000e7;ois</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Boffa</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Hummel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bernadet-Monrozies</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fouque</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Canou&#x000ef;-Poitrine</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Daugas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Audard</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Acute renal infarction: a case series.</article-title>
            <source>Clin J Am Soc Nephrol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>392</fpage>
            <page-range>392-8</page-range>
            <pub-id pub-id-type="pmid">23204242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pizzarossa</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>M&#x000e9;rola</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>[Etiology of renal infarction. A systematic review].</article-title>
            <source>Rev Med Chil</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>147</volume>
            <issue>7</issue>
            <fpage>891</fpage>
            <page-range>891-900</page-range>
            <pub-id pub-id-type="pmid">31859988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mesiano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rollino</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Beltrame</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quattrocchio</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fenoglio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pozzato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cecere</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Forneris</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bazzan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Macchia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Roccatello</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Acute renal infarction: a single center experience.</article-title>
            <source>J Nephrol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-107</page-range>
            <pub-id pub-id-type="pmid">26743079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Na</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Risk factors and outcomes of acute renal infarction.</article-title>
            <source>Kidney Res Clin Pract</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>90</fpage>
            <page-range>90-5</page-range>
            <pub-id pub-id-type="pmid">27366663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oh</surname>
                <given-names>YK</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Clinical Characteristics and Outcomes of Renal Infarction.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>243</fpage>
            <page-range>243-50</page-range>
            <pub-id pub-id-type="pmid">26545635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caravaca-Font&#x000e1;n</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pampa Saico</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>El&#x000ed;as Trivi&#x000f1;o</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Galeano &#x000c1;lvarez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gomis Couto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pecharrom&#x000e1;n de las Heras</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lia&#x000f1;o</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Acute renal infarction: Clinical characteristics and prognostic factors.</article-title>
            <source>Nefrologia</source>
            <year>2016</year>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-8</page-range>
            <pub-id pub-id-type="pmid">26698927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hall</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Acute renal vascular occlusion: an uncommon mimic.</article-title>
            <source>J Emerg Med</source>
            <year>1993</year>
            <season>Nov-Dec</season>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>691</fpage>
            <page-range>691-700</page-range>
            <pub-id pub-id-type="pmid">8157906</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henry</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>MacEneaney</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Browne</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous renal artery dissection: an elusive diagnosis.</article-title>
            <source>BMJ Case Rep</source>
            <year>2021</year>
            <month>Sep</month>
            <day>27</day>
            <volume>14</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">34580135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuo</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Impact of Renal Artery Stent-Graft Placement on Renal Function in Chronic Aortic Dissection.</article-title>
            <source>J Vasc Interv Radiol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>7</issue>
            <fpage>979</fpage>
            <page-range>979-986</page-range>
            <pub-id pub-id-type="pmid">30982639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varennes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tahon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kastler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thony</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baguet</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Detante</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Touz&#x000e9;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Krainik</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Fibromuscular dysplasia: what the radiologist should know: a pictorial review.</article-title>
            <source>Insights Imaging</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-307</page-range>
            <pub-id pub-id-type="pmid">25926266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van den Driessche</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van Hul</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ichiche</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Verpooten</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Bosmans</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Fibromuscular dysplasia presenting as a renal infarction: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2010</year>
            <month>Jun</month>
            <day>30</day>
            <volume>4</volume>
            <fpage>199</fpage>
            <pub-id pub-id-type="pmid">20591148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abi Doumet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bustos</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Garrell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Salman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haider</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Fibromuscular Dysplasia Presenting as Acute Unilateral Renal Infarction: A Case Report and Review of Two Diseases.</article-title>
            <source>Cureus</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>e35933</fpage>
            <pub-id pub-id-type="pmid">37038580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Baradhi</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Bream</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Fibromuscular Dysplasia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>10</day>
            <pub-id pub-id-type="pmid">29630256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antopolsky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simanovsky</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stalnikowicz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Salameh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hiller</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Renal infarction in the ED: 10-year experience and review of the literature.</article-title>
            <source>Am J Emerg Med</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>7</issue>
            <fpage>1055</fpage>
            <page-range>1055-60</page-range>
            <pub-id pub-id-type="pmid">21871764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saarinen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Palom&#x000e4;ki</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute renal infarction resulting from fibromuscular dysplasia: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2016</year>
            <month>May</month>
            <day>10</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>118</fpage>
            <pub-id pub-id-type="pmid">27159998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bemanian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Motallebi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nosrati</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Cocaine-induced renal infarction: report of a case and review of the literature.</article-title>
            <source>BMC Nephrol</source>
            <year>2005</year>
            <month>Sep</month>
            <day>22</day>
            <volume>6</volume>
            <fpage>10</fpage>
            <pub-id pub-id-type="pmid">16176587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ammous</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghaffar</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>El-Charabaty</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>El-Sayegh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Renal infarction in COVID-19 patient.</article-title>
            <source>J Nephrol</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>267</fpage>
            <page-range>267-268</page-range>
            <pub-id pub-id-type="pmid">33119839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spargo</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Wit</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Meehan</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>433</fpage>
            <page-range>433-47</page-range>
            <pub-id pub-id-type="pmid">10692269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rudnick</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Berns</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Goldfarb</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review.</article-title>
            <source>Am J Kidney Dis</source>
            <year>1994</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>713</fpage>
            <page-range>713-27</page-range>
            <pub-id pub-id-type="pmid">7942832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scolari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ravani</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Atheroembolic renal disease.</article-title>
            <source>Lancet</source>
            <year>2010</year>
            <month>May</month>
            <day>08</day>
            <volume>375</volume>
            <issue>9726</issue>
            <fpage>1650</fpage>
            <page-range>1650-60</page-range>
            <pub-id pub-id-type="pmid">20381857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mannesse</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Blankestijn</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Man in 't Veld</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Schalekamp</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Renal failure and cholesterol crystal embolization: a report of 4 surviving cases and a review of the literature.</article-title>
            <source>Clin Nephrol</source>
            <year>1991</year>
            <month>Nov</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>240</fpage>
            <page-range>240-5</page-range>
            <pub-id pub-id-type="pmid">1752074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thadhani</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Camargo</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Xavier</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Bazari</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1995</year>
            <month>Nov</month>
            <volume>74</volume>
            <issue>6</issue>
            <fpage>350</fpage>
            <page-range>350-8</page-range>
            <pub-id pub-id-type="pmid">7500898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Bayliss</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cholesterol Crystal Embolism and Chronic Kidney Disease.</article-title>
            <source>Int J Mol Sci</source>
            <year>2017</year>
            <month>May</month>
            <day>24</day>
            <volume>18</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">28538699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ivanes</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dewaele</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Touboul</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gatault</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sautenet</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Barbet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>B&#x000fc;chler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quilliet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Angoulvant</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Halimi</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Renal arteriography with endovascular ultrasound for the management of renal infarction patients.</article-title>
            <source>BMC Nephrol</source>
            <year>2020</year>
            <month>Jul</month>
            <day>14</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>273</fpage>
            <pub-id pub-id-type="pmid">32664890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Domanovits</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Paulis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nikfardjam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meron</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>K&#x000fc;rkciyan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bankier</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Laggner</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Acute renal infarction. Clinical characteristics of 17 patients.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>78</volume>
            <issue>6</issue>
            <fpage>386</fpage>
            <page-range>386-94</page-range>
            <pub-id pub-id-type="pmid">10575421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Yen</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>ED presentations of acute renal infarction.</article-title>
            <source>Am J Emerg Med</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-9</page-range>
            <pub-id pub-id-type="pmid">17276805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komolafe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dishmon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sultan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Khouzam</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Successful aspiration and rheolytic thrombectomy of a renal artery infarct and review of the current literature.</article-title>
            <source>Can J Cardiol</source>
            <year>2012</year>
            <season>Nov-Dec</season>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>760.e1</fpage>
            <page-range>760.e1-3</page-range>
            <pub-id pub-id-type="pmid">22906801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>De La Garza</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>De Zepeda Diaz</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Maymone</surname>
                <given-names>MBC</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Secemsky</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vashi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Part II: Cutaneous manifestations of peripheral vascular disease.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>89</volume>
            <issue>2</issue>
            <fpage>211</fpage>
            <page-range>211-226</page-range>
            <pub-id pub-id-type="pmid">35504485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fine</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kapoor</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Falanga</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Cholesterol crystal embolization: a review of 221 cases in the English literature.</article-title>
            <source>Angiology</source>
            <year>1987</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>10</issue>
            <fpage>769</fpage>
            <page-range>769-84</page-range>
            <pub-id pub-id-type="pmid">3310742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Korzets</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Plotkin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bernheim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zissin</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The clinical spectrum of acute renal infarction.</article-title>
            <source>Isr Med Assoc J</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>4</volume>
            <issue>10</issue>
            <fpage>781</fpage>
            <page-range>781-4</page-range>
            <pub-id pub-id-type="pmid">12389340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fukumoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tsutsui</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsuchihashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Masumoto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takeshita</surname>
                <given-names>A</given-names>
              </name>
              <collab>Cholesterol Embolism Study(CHEST) Investigators</collab>
            </person-group>
            <article-title>The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2003</year>
            <month>Jul</month>
            <day>16</day>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>211</fpage>
            <page-range>211-6</page-range>
            <pub-id pub-id-type="pmid">12875753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Early Diagnosis and Intervention of Acute Renal Infarction with Catheter-Directed Thrombolytic Therapy.</article-title>
            <source>Acta Cardiol Sin</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>134</fpage>
            <page-range>134-140</page-range>
            <pub-id pub-id-type="pmid">35273434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r38">
          <label>38</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kaufman</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Mahabadi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Munakomi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <chapter-title>Hollenhorst Plaque</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>1</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">29261979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paris</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bobrie</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rossignol</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Le Coz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chedid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plouin</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>Blood pressure and renal outcomes in patients with kidney infarction and hypertension.</article-title>
            <source>J Hypertens</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>1649</fpage>
            <page-range>1649-54</page-range>
            <pub-id pub-id-type="pmid">16877969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gasparini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hofmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stoller</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Renal artery embolism: clinical features and therapeutic options.</article-title>
            <source>J Urol</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>147</volume>
            <issue>3</issue>
            <fpage>567</fpage>
            <page-range>567-72</page-range>
            <pub-id pub-id-type="pmid">1538430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolderman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Oyen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Verrijcken</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Knockaert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vanderschueren</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic renal infarction.</article-title>
            <source>Am J Med</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>119</volume>
            <issue>4</issue>
            <fpage>356.e9</fpage>
            <page-range>356.e9-12</page-range>
            <pub-id pub-id-type="pmid">16564787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winzelberg</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Hull</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Agar</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Pletka</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Elevation of serum lactate dehydrogenase levels in renal infarction.</article-title>
            <source>JAMA</source>
            <year>1979</year>
            <month>Jul</month>
            <day>20</day>
            <volume>242</volume>
            <issue>3</issue>
            <fpage>268</fpage>
            <page-range>268-9</page-range>
            <pub-id pub-id-type="pmid">448917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Salazer</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Farkouh</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Eosinophiluria in atheroembolic renal disease.</article-title>
            <source>Am J Med</source>
            <year>1991</year>
            <month>Aug</month>
            <volume>91</volume>
            <issue>2</issue>
            <fpage>186</fpage>
            <page-range>186-9</page-range>
            <pub-id pub-id-type="pmid">1867244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cosio</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Zager</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Atheroembolic renal disease causes hypocomplementaemia.</article-title>
            <source>Lancet</source>
            <year>1985</year>
            <month>Jul</month>
            <day>20</day>
            <volume>2</volume>
            <issue>8447</issue>
            <fpage>118</fpage>
            <page-range>118-21</page-range>
            <pub-id pub-id-type="pmid">2862317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kasinath</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilia as a clue to the diagnosis of atheroembolic renal disease.</article-title>
            <source>Arch Intern Med</source>
            <year>1987</year>
            <month>Aug</month>
            <volume>147</volume>
            <issue>8</issue>
            <fpage>1384</fpage>
            <page-range>1384-5</page-range>
            <pub-id pub-id-type="pmid">3632147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haqqie</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Urizar</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Nephrotic-range proteinuria in renal atheroembolic disease: report of four cases.</article-title>
            <source>Am J Kidney Dis</source>
            <year>1996</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>493</fpage>
            <page-range>493-501</page-range>
            <pub-id pub-id-type="pmid">8840937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fries</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Roos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gaspert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vogt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Salomon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>W&#x000fc;thrich</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Vavricka</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Fehr</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Atheroembolic disease--a frequently missed diagnosis: results of a 12-year matched-pair autopsy study.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>89</volume>
            <issue>2</issue>
            <fpage>126</fpage>
            <page-range>126-132</page-range>
            <pub-id pub-id-type="pmid">20517183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greenberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bastacky</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Iqbal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borochovitz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations.</article-title>
            <source>Am J Kidney Dis</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>334</fpage>
            <page-range>334-44</page-range>
            <pub-id pub-id-type="pmid">9041208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hazanov</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Somin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Attali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Beilinson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thaler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mouallem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maor</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zaks</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Malnick</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Acute renal embolism. Forty-four cases of renal infarction in patients with atrial fibrillation.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2004</year>
            <month>Sep</month>
            <volume>83</volume>
            <issue>5</issue>
            <fpage>292</fpage>
            <page-range>292-299</page-range>
            <pub-id pub-id-type="pmid">15342973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yanagita</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The cortical rim sign in graft renal infarction.</article-title>
            <source>Clin Exp Nephrol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>1169</fpage>
            <page-range>1169-1170</page-range>
            <pub-id pub-id-type="pmid">31214873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piccoli</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Priola</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Vigotti</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Guzzo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Veltri</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Renal infarction versus pyelonephritis in a woman presenting with fever and flank pain.</article-title>
            <source>Am J Kidney Dis</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>311</fpage>
            <page-range>311-4</page-range>
            <pub-id pub-id-type="pmid">24767880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lengel&#x000e9;</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Christophe</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Persu</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Renal infarction management: towards an etiological approach?</article-title>
            <source>J Hypertens</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>490</fpage>
            <page-range>490-492</page-range>
            <pub-id pub-id-type="pmid">29384986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Intravascular ultrasound provides additional insights in the hypertensive patients with focal renal artery fibromuscular dysplasia.</article-title>
            <source>Hypertens Res</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>1407</fpage>
            <page-range>1407-1416</page-range>
            <pub-id pub-id-type="pmid">36765108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greenberg</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Acute renal artery thrombosis treated by percutaneous rheolytic thrombectomy.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2002</year>
            <month>May</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>66</fpage>
            <page-range>66-8</page-range>
            <pub-id pub-id-type="pmid">11979537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silverberg</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Menes</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rimon</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Salomon</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Halak</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Acute renal artery occlusion: Presentation, treatment, and outcome.</article-title>
            <source>J Vasc Surg</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>1026</fpage>
            <page-range>1026-32</page-range>
            <pub-id pub-id-type="pmid">27345378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>AKH</given-names>
              </name>
            </person-group>
            <article-title>Successful rescue from kidney failure with delayed catheter-directed intervention after catastrophic bilateral kidney paradoxical thromboembolism.</article-title>
            <source>BMJ Case Rep</source>
            <year>2022</year>
            <month>Feb</month>
            <day>10</day>
            <volume>15</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">35144961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koivuviita</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tertti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heiro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manner</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mets&#x000e4;rinne</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Thromboembolism as a cause of renal artery occlusion and acute kidney injury: the recovery of kidney function after two weeks.</article-title>
            <source>Case Rep Nephrol Urol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>82</fpage>
            <page-range>82-7</page-range>
            <pub-id pub-id-type="pmid">24847350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heidemann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>K&#x000f6;lbel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Debus</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Diener</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Rohlffs</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tsilimparis</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Renal Function Salvage After Delayed Endovascular Revascularization of Acute Renal Artery Occlusion in Patients With Fenestrated-Branched Endovascular Aneurysm Repair or Visceral Debranching.</article-title>
            <source>J Endovasc Ther</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>466</fpage>
            <page-range>466-473</page-range>
            <pub-id pub-id-type="pmid">29956578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robinson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Macleod</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Duncan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Acute renal artery embolism: a case report and brief literature review.</article-title>
            <source>Ann Vasc Surg</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>145</fpage>
            <page-range>145-7</page-range>
            <pub-id pub-id-type="pmid">18083341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassanein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saleh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Randhawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karve</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Renal artery embolism successfully managed by ultrasound enhanced catheter directed thrombolysis.</article-title>
            <source>Egypt Heart J</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>447</fpage>
            <page-range>447-450</page-range>
            <pub-id pub-id-type="pmid">30591770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karakurt</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>New Thrombolytic Infusion Application of Dissolving Renal Artery Embolic Thrombosis: Low-Dose Slow-Infusion Thrombolytic Therapy.</article-title>
            <source>Case Rep Nephrol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>1609025</fpage>
            <pub-id pub-id-type="pmid">29854504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chondros</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Karpathakis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tsetis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sofras</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mamoulakis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Systemic thrombolysis with the use of tenecteplase for segmental acute renal in-farction potentially associated with multiple thrombophilic gene polymorphisms.</article-title>
            <source>Hippokratia</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-70</page-range>
            <pub-id pub-id-type="pmid">25125956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhen</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Lieske</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>McBane</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Grande</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sandhu</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Melduni</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Cholesterol Embolization Syndrome in the Setting of an Acute Indication for Anticoagulation Therapy.</article-title>
            <source>J Med Cases</source>
            <year>2014</year>
            <month>Jun</month>
            <day>01</day>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>376</fpage>
            <page-range>376-379</page-range>
            <pub-id pub-id-type="pmid">25197328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belenfant</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Meyrier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jacquot</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Supportive treatment improves survival in multivisceral cholesterol crystal embolism.</article-title>
            <source>Am J Kidney Dis</source>
            <year>1999</year>
            <month>May</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>840</fpage>
            <page-range>840-50</page-range>
            <pub-id pub-id-type="pmid">10213638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scolari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ravani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guerini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zubani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Movilli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Savoldi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malberti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Maiorca</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>1584</fpage>
            <page-range>1584-90</page-range>
            <pub-id pub-id-type="pmid">12761259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colburn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Childers</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Chacon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Swailes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Sahi</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The cost of seeking an edge: Recurrent renal infarction in setting of recreational use of anabolic steroids.</article-title>
            <source>Ann Med Surg (Lond)</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>14</volume>
            <fpage>25</fpage>
            <page-range>25-28</page-range>
            <pub-id pub-id-type="pmid">28127424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bae</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Jeon</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>A retrospective study of short- and long-term effects on renal function after acute renal infarction.</article-title>
            <source>Ren Fail</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>9</issue>
            <fpage>1385</fpage>
            <page-range>1385-9</page-range>
            <pub-id pub-id-type="pmid">25112371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwon</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Ha</surname>
                <given-names>SO</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Do</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Renal Complications in Patients with Renal Infarction: Prevalence and Risk Factors.</article-title>
            <source>Kidney Blood Press Res</source>
            <year>2016</year>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>865</fpage>
            <page-range>865-872</page-range>
            <pub-id pub-id-type="pmid">27871081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143520.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heung</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Predicting progression to chronic kidney disease after recovery from acute kidney injury.</article-title>
            <source>Curr Opin Nephrol Hypertens</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>628</fpage>
            <page-range>628-34</page-range>
            <pub-id pub-id-type="pmid">23010757</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
